Abstract
The effect of levocabastine, a new specific H1 antagonist, has been investigated against a placebo in nasal provocation tests on 42 allergic patients divided into two parallel groups. The results obtained show that it significantly inhibited the nasal reaction to the allergen and seems to have a long-lasting effect in allergic patients.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
MeSH terms
-
Administration, Intranasal
-
Adolescent
-
Adult
-
Female
-
Histamine H1 Antagonists / administration & dosage
-
Histamine H1 Antagonists / therapeutic use*
-
Humans
-
Male
-
Middle Aged
-
Nasal Provocation Tests*
-
Piperidines / administration & dosage
-
Piperidines / therapeutic use*
-
Rhinitis / diagnosis*
Substances
-
Histamine H1 Antagonists
-
Piperidines
-
levocabastine